(MENAFN) Becton Dickinson and Co, a US-based medical technology company, has set its goal to a 17 percent increase in sales from China in 2015 to approximately USD600 million.
In reassurance to the success of the plan, medical devices, especially the infusion business, is still the largest revenue earner in China, plus the country is already Becton Dickinson's second largest market.
China has recently witnessed a huge demand for products like needles and quick diagnostic kits, let alone factors like an accelerated aging population and growing rate of chronic and serious diseases has boosted China's medical device market.
It's predicted that China will be the world's second-largest medical technology market with a value of USD55 billion by 2020 and an average annual progress of 14 percent.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.